Source-backed guidance for evaluating whether Dysport or Botox may be appropriate for your treatment goals, with key differences in formulation, dosing, and safety considerations.
Last reviewed: 2026-05-06
9 min read
Ready to explore your options in Istanbul?
Connect with our coordination team for a personalised treatment plan, verified provider matching, and travel logistics support.
Content is educational and planning-oriented. It does not replace diagnosis, treatment, or personalized medical advice from a licensed healthcare professional. Outcomes vary by individual case.
Dysport and Botox are not interchangeable by unit—a 2.5-3:1 conversion ratio means more Dysport units are required for equivalent effects.
Botox holds FDA approval for three cosmetic areas (glabellar lines, crow's feet, forehead lines), while Dysport is approved primarily for glabellar lines.
Dysport contains cow's milk protein, making it contraindicated for patients with dairy allergies.
Provider expertise matters more than product choice—an experienced injector using either product typically achieves better outcomes than an inexperienced injector.
Both products carry boxed warnings about potential spread of effects beyond the injection site.
Educational information only
This content is general education and does not replace evaluation by a licensed clinician. If you have symptoms, complications, or urgent concerns, seek in-person medical care.
Core Context — Understanding Dysport and Botox
Both Dysport and Botox contain botulinum toxin type A as their active ingredient, but they differ in their protein complexes, manufacturing processes, and regulatory approvals. These differences affect how each product spreads in tissue, how quickly results appear, and how long effects may last.
Botox Cosmetic (onabotulinumtoxinA) received initial FDA approval in 2002 for glabellar lines and subsequently expanded to crow's feet (2013) and forehead lines (2017) [S2]. This makes Botox the only neurotoxin currently approved by the FDA for all three major upper facial treatment areas. Dysport (abobotulinumtoxinA) is FDA-approved for glabellar lines and various therapeutic indications (cervical dystonia, spasticity), but does not have FDA approval for crow's feet or forehead lines as a cosmetic treatment [S1].
Why regulatory approval matters
Regulatory approval status affects how providers can market and recommend products. Off-label use—treating areas not specifically approved—is legal and common in medical practice, but less regulatory guidance exists for dosing in these areas.
Understanding these products requires recognizing that they are not direct substitutes. The units represent different biological activity levels, and pricing structures reflect these differences. Some clinics price Dysport lower per unit but require more units to achieve comparable results.
For international medical travelers, regulatory approval may vary by country. Products approved in one jurisdiction may have different status elsewhere. Consulting with a qualified provider familiar with local regulations ensures appropriate product selection. Our injectables and botulinum toxin hub provides additional context on these treatments.
Key formulation difference
Dysport contains cow's milk protein (lactose and serum albumin from milk), which is a specific contraindication for patients with dairy allergies [S1]. Botox does not contain this ingredient.
Decision Criteria — Key Factors for Your Choice
Several factors influence whether Dysport or Botox may be more appropriate for your individual circumstances. Your provider should consider these elements during consultation.
Previous response to botulinum toxin plays a significant role. If you have previously responded well to one product, your provider may recommend continuing with that option. Patients who have developed resistance to one product due to antibody formation may respond to another, though this occurs infrequently.
Treatment area affects product selection. For areas specifically approved by regulators (glabellar lines, crow's feet, forehead lines), your provider can recommend based on evidence for that indication. For off-label areas such as neck bands, jawline slimming, or masseter reduction, provider experience becomes more influential than product labeling [S4]. Explore our treatment options for available areas and approaches.
Onset and duration expectations may vary between products. Clinical observations suggest Dysport may show results slightly faster in some patients (2-3 days versus 3-5 days for Botox), and effects may persist slightly longer (3-4 months versus 3 months for Botox) [S3]. However, individual response varies considerably, and these generalizations do not apply uniformly.
Allergy considerations are critical. Dysport's cow's milk protein content means it is contraindicated for patients with dairy allergies. Patients with known milk protein allergies should avoid Dysport regardless of other potential benefits [S1].
Cost discussions should account for the conversion ratio. Because Dysport requires approximately 2.5-3 units for every 1 unit of Botox [S3], comparing prices requires understanding the total treatment cost rather than per-unit pricing alone.
Source-Backed Facts — What Clinical Evidence Shows
Clinical research provides evidence-based insights into how these products compare in practice.
Dosing and Conversion Ratios
Systematic reviews of clinical conversion ratios establish that Dysport requires approximately 2.5-3 units for every 1 unit of Botox to achieve equivalent muscle relaxation [S3]. This conversion factor has been validated across multiple studies including randomized controlled trials for cervical dystonia and blepharospasm. Conversion ratios of 4:1 or higher have resulted in excessive dosing and increased adverse events in clinical studies [S3].
The conversion ratio is not merely academic—it directly affects treatment cost. When comparing providers or destinations, understanding whether pricing reflects per-unit costs or total treatment costs enables more informed comparisons.
Diffusion and Spread Characteristics
Research suggests Dysport may have slightly greater diffusion properties compared to Botox, which can be advantageous for treating larger muscle areas but requires more precise injection placement to avoid unintended effects [S3]. Studies indicate that toxin spread depends more on injection technique, volume, and concentration than on the specific product formulation [S4].
The theoretical differences in protein complex size (approximately 900 kDa for Botox versus 300-500 kDa for Dysport) may not translate to clinically significant differences in routine cosmetic use for most patients [S3].
Safety Profile Comparison
Both products share similar contraindications and potential side effects. Absolute contraindications include hypersensitivity to any botulinum toxin product or formulation components [S1][S2]. Relative contraindications include neuromuscular disorders (myasthenia gravis, ALS), pregnancy, breastfeeding, and certain medication interactions (aminoglycosides, muscle relaxants).
Feature
Dysport
Botox
FDA-approved cosmetic indications
Glabellar lines only
Glabellar lines, crow's feet, forehead lines
Active ingredient
AbobotulinumtoxinA
OnabotulinumtoxinA
Dairy protein content
Yes (cow's milk)
No
Typical onset
2-3 days
3-5 days
Estimated duration
3-4 months
3 months
Conversion ratio reference
2.5-3:1 vs Botox
1:1 baseline
Risk Controls — Safety Considerations for Patients
Both products carry FDA boxed warnings regarding the potential spread of toxin effects beyond the injection site, which can cause serious adverse effects including muscle weakness, dysphagia, and respiratory compromise [S1][S2]. While these serious complications are rare when treatments are administered by qualified providers, understanding warning signs is important.
Absolute Contraindications
Hypersensitivity to any botulinum toxin product or formulation components
Infection at the proposed injection site
Cow's milk protein allergy (Dysport specifically) [S1]
Use of medications that affect neuromuscular function (aminoglycosides, muscle relaxants, anticholinergics)
Bleeding disorders or anticoagulant therapy
Previous adverse response to botulinum toxin treatment
Warning signs requiring medical attention
Seek prompt medical evaluation if you experience: difficulty swallowing, slurred speech, muscle weakness spreading beyond the injection site, vision problems, loss of bladder control, or breathing difficulties.
Provider Qualifications
Neither product is inherently safer than the other—the outcome depends heavily on injector expertise, proper dosing, and anatomical understanding [S4]. When selecting a provider, consider their training and certification, years of experience with neurotoxin injections, before-and-after photographs of their actual patients, and their approach to consultation and informed consent. Our directory of qualified providers offers verification guidance and credential standards.
For international patients, verifying provider credentials in their jurisdiction is essential. Different countries have varying regulations regarding who can administer injectable treatments and what training or certification is required. Verify that your chosen facility maintains proper accreditation and emergency protocols.
Action Checklist — Preparing for Your Consultation
Use this checklist when discussing treatment options with your provider:
Before your appointment:
Compile complete medical history including allergies, medications, and previous reactions
Research provider credentials and read patient reviews from verified sources
Prepare questions about product options, dosing, and expected outcomes
Understand pricing structures and ask for total treatment cost estimates
Questions to ask your provider:
Which product do you recommend for my treatment goals, and why?
What is your experience with this product for my specific treatment area?
How do you determine dosing, and what is the conversion ratio if switching products?
What are the specific risks for my medical history?
What should I expect during recovery, and when should I expect results?
What follow-up is included if I need adjustment?
Red flags when selecting a provider:
Pressure to book immediately without consultation
Reluctance to discuss credentials, training, or experience
Pricing that seems too good to be true
Guarantees of specific outcomes
Unwillingness to discuss risks or answer questions
Treatment in non-medical settings without proper sanitation protocols
Pre-treatment preparation:
Avoid blood-thinning medications and supplements (as directed by your provider)
Disclose all medications including over-the-counter and herbal products
Avoid alcohol for 24 hours before treatment
Arrive with clean skin, free of makeup or skincare products
Plan transportation if treatment involves areas affecting facial expression
For patients traveling internationally for treatment, coordinate with your provider regarding consultation timing, treatment scheduling, and follow-up arrangements before booking travel. Our travel coordination team can assist with appointment scheduling and logistics planning.
Travel planning for international patients
If traveling for treatment, consider scheduling a virtual consultation before arrival when possible. This allows initial assessment and reduces time required on-site. Plan for potential touch-up appointments and understand the provider's policy for complications or dissatisfaction.
Next Steps
Schedule a consultation with a qualified provider to discuss which product may be appropriate for your individual goals and medical profile. Your provider can assess your candidacy, recommend appropriate dosing, and develop a treatment plan based on your specific anatomy and objectives.
